Aziyo voluntarily recalls viable bone matrix products after two MTB infections

ELUTIA INC.

Voluntary recall of all viable bone matrix products used in orthopedic/spinal procedures.
Two patients treated with product from a single donor lot developed post-surgical Mycobacterium tuberculosis infections.
Shipments of all viable bone matrix products from all donor lots suspended out of caution.
Company coordinating with FDA and CDC to investigate source and notify physicians for post-exposure prophylaxis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.